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1 - ORIGINAL ARTICLE
MODELS, BIOLOGICAL
Engraftment of human adipose derived stem cells delivered in a hyaluronic acid 
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ABSTRACT
PURPOSE: To evaluate the implant of human adipose derived stem cells (ADSC) delivered in hyaluronic acid gel (HA), injected in the 
subcutaneous of athymic mice. 
METHODS: Control implants -HA plus culture media was injected in the subcutaneous of the left sub scapular area of 12 athymic 
mice. ADSC implants: HA plus ADSC suspended in culture media was injected in the subcutaneous, at the contra lateral area, of the 
same animals. With eight weeks, animals were sacrificed and the recovered implants were processed for extraction of genomic DNA, 
and histological study by hematoxilin-eosin staining and immunufluorescence using anti human vimentin and anti von Willebrand factor 
antibodies.
RESULTS: Controls: Not visualized at the injection site. An amorphous substance was observed in hematoxilin-eosin stained sections. 
Human vimentin and anti von Willebrand factor were not detected. No human DNA was detected. ADSC implants - A plug was visible 
at the site of injection. Fusiform cells were observed in sections stained by hematoxilin- eosin and both human vimentin and anti von 
Willebrand factor were detected by immunofluorescence. The presence of human DNA was confirmed. 
CONCLUSION: The delivery of human adipose derived stem cells in preparations of hyaluronic acid assured cells engraftment at the 
site of injection.
Key words: Adult Stem Cells. Tissue Engineering. Cell Transplantation. Adipose Tissue. Hyaluronic Acid. Biocompatible Materials. 
Mice.
RESUMO
OBJETIVO: Avaliar o implante de células tronco do tecido adiposo humano (CTTAH) em gel de ácido hialurônico (AH), injetados no 
tecido subcutâneo de camundongos atímicos. 
MÉTODOS: Implantes controle - HA com meio de cultura foram injetados no tecido subcutâneo da região infraescapular esquerda de 
12 camundongos atímicos. Implantes de CTTAH: HA com CTTAH suspensas em meio de cultura foi injetado no subcutâneo da região 
contra lateral, dos mesmos animais. Com oito semanas, os animais foram sacrificados e os implantes recuperados foram processados 
para extração de DNA genômico, estudo histológico por coloração por hematoxilina eosina e imnuoflurescência utilizando anticorpos 
anti vimentina humana e anti fator de von Willebrand. 
RESULTADOS: Controles - implantes não visualizados no local da injeção. Uma substância amorfa foi observada nos cortes corados 
por hematoxilina eosina. Vimentina humana e fator anti von Willebrand não foram identificados. DNA humano não foi detectado. 
Implantes de CTTAH - Uma massa era visível no local da injeção. Células fusiformes foram observadas nos corte corados com 
hematoxilina eosina. Tanto vimentina humana quanto fator de von Willebrand foram identificados pela imunofluorescência. A presença 
de DNA humano foi confirmada. 
CONCLUSÃO: O implante de células tronco do tecido adiposo humano em veículo de ácido hialurônico gel assegurou a manutenção 
das células no local do implante.  
Descritores: Células-Tronco Adultas. Engenharia Tecidual. Transplante de Células. .Tecido Adiposo. Ácido Hialurônico. Materiais 
Biocompatíveis. Camundongos.
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Introduction
Adipose derived stem cells (ADSC) can be easily isolated 
from human lipoaspirate fat and are able to differentiate in other 
cell types like muscle, cartilage, and bone cells, as first-handed 
by Zuk et al.1,2. When compared to bone marrow, adipose tissue 
yields 100 to 1000 times more stem cells3-5. 
Some clinical trials have already tested the therapeutic 
potential of autologous ADSC and achieved positive results in 
cardiac ischemia6, wound closure of irradiated areas7 and treatment 
of complex fistulas in Chron’s disease8.
Despite the encouraging results from early clinical 
studies with adult stem cells, there is no consistent evidence that 
autologous stem cells can survive, engraft and exerts their specific 
role in vivo9. Previous studies have demonstrated that to provide 
a scaffold, to serve as extra cellular matrix, allows cell attachment 
that is necessary to establish intercellular contact and signaling 
that ultimately leads to tissue organization10,11. 
Several biocompatible materials have been investigated 
as potential scaffolds for ADSC like collagen, placental decellular 
matrix, 5, isopropylacrylamide microspheres, gelatin, poly(D,L-
lactic-co-glycolic acid),  fibrin, Matrigel, and hyaluronic acid in 
sponges, nonwoven meshes,  aminated hydrogels and copolymers, 
with varying results12,13. 
Among them, hyaluronic acid gel (HA) has the 
advantage of being injectable, non-immunogenic, non-cytotoxic 
and approved for medical use as a filler14,15.Therefore, the 
possibility of delivering ADSC by a simple injection, assuring 
their pervasiveness at the site of injection, makes HA crosslinked 
gel a suitable scaffold to be tested for that purpose.
In this work we have studied the engraftment of human 
ADSC delivered in preparations of hyaluroinic acid gel, in the 
subcutaneous tissue of athymic mice. 
Methods 
The study was conducted in accordance with the 
regulations of the Ethics Committee of Nice-Sophia Antipolis 
University and the French Animal Protection Laws. Twelve 
athymic mice (Swiss nu/nu), 8-10 week-old, received intra 
peritoneal anesthesia with ketamin (Imalgene, Merial, 90m\
kg) and xylazin (Rompum, Bayer, 4.5mg\kg). Under aseptic 
conditions, each animal was injected with the ADSC implant 
in the subcutaneous of the right sub scapular area and with the 
control implant in the subcutaneous of the left sub scapular area. 
We performed the injections in three different series (four animals 
per series) using cells from one donor in each series. 
Isolation and expansion of ADSC
After informed consent, three female patients, 
undergoing liposuction for aesthetic reasons donated, each one, 
100ml of lipoaspirate fat from tights. Patients were 28, 36 and 43 
years old and had normal corporal mass index. The liposuction 
was performed by syringe aspiration system after local infiltration 
with a solution of adrenalin (1:200.000) and lydocain (0.33%). 
The adipose tissue was processed as described by Negrel and 
Dani16. Briefly, the lipoaspirate fat was washed with PBS until 
cleared of blood and digested in DMEM (Dulbelcco’s modified 
Eagle medium-Gibco BRL, Gergy Pontoise, France), added 
with 2mg/ml of  collagenase (Boerhinger), 20mg/ml of serum 
albumin fraction 5 (Sigma) and antibiotics (penicillin 124µg/ml, 
streptomycin 100µg/ml). Digestion was interrupted by addition of 
10% of fetal calf serum (FCS) (Dutscher SA; Brumath, France) 
.The digested tissue was centrifuged for 5 minutes at 200g and 
supernatant digests were discharged. The pellet was suspended 
and   seeded in tissue culture dishes (CellStar) at the reason of 
3x104 cells/cm2 with plating media (DMEM supplemented with 
10% FCS plus antibiotics). On the following day, culture dishes 
were washed to remove non-adherent cells and received plating 
media that was changed every other day.  ASDC from the 2nd 
passage were processed for Fluorescence Activated Cell Sorting 
(FACS) and implanted in the animals.
FACS analyses of expanded ADSC
Expanded ADSC from each donor were processed 
separately as follows: cells were fixed for 30 min in 2% para-
formaldehyde. Fixed cells were washed in flow cytometry buffer 
(FCB: 1X PBS; 2%FBS and 0.2% Tween 20). Aliquots of 1X106 
cells were incubated for 30 min with FCB containing Fluorescein 
isothiocyanate (FITC) or R-phycoerytherin (PE) conjugated 
antibodies: anti CD45-FITC, CD14-PE, CD34-PE, CD13-PE, 
HLA-DR-FITC, CD90-PE, CD 44-FITC, CD29-FITC (Becton 
Dickinson), anti HLA classe1-PE, CD54-PE, e CD49e-PE, CD 
51/61-FITC (Pharmingen) and anti KDR (Sigma). Anti KDR 
antibody was revealed by indirect immunofluorescence; cells were 
washed with PBS and incubated with FCB containing the secondary 
antibody: goat anti mouse IgG-FITC (Sigma). Isotype-matched 
control antibodies were used in order to accurately determine 
the level of specific binding. Flow cytometry was performed 
with a Fluorescence Activated Cell Sorting (FACS) argon laser 
cytometer (BDIS -Becton Dickinson Immunodiagnostic Systems) 
and acquired data were analyzed by Cell Quest (BDIS) program. 
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Positive staining was defined as a fluorescent intensity greater than 
99% of that obtained with the isotype-matched control antibody.
Implants preparation  
Under aseptic conditions, 1x106 of expanded ADSC were 
suspended in 0.2 ml of DMEM and mixed with 0.6 ml of cross-
linked hyaluronic acid gel (Juvederm 30). To serve as control, 
0.6ml of the same gel was mixed with 0.2 ml of DMEM only. 
Preparations were kept at 37oC and 5% CO2, for 24h. On the 
following day, two hours before the injection in the animals, 10ng/
ml of basic fibroblast growth factor (bFGF) was added to controls 
as well to ADSC containing syringes.
Recovery and analysis of implants
Animals (N=12) were sacrificed by vertebral dislocation 
at two months of the date of the injections. Twelve pairs of 
implants, i.e. 12 ADSC implants and their respective controls, 
were recovered after the harvest of a dorsal, caudal based flap 
and macroscopically analyzed regarding color, consistence 
and vascularization. Following, implants were frozen in liquid 
nitrogen and kept at - 80oC. Randomly, one pair of implants of 
each series was saved for DNA extraction and amplification and 
the remaining 3 pairs of each series were embedded in Tissue Tek 
OCT compound   (Miles Inc., IN, USA) until sectioning in 6µm 
sections.
Histological analysis
Representative sections obtained from each implant were 
separately analyzed through light microscopic after hematoxilin-
eoisn staining. Immunofluorescence: to identify human cells, 
sections were incubated with specific anti- human-vimentin 
mouse monoclonal antibody (V9 clone, Novo Castra Laboratories; 
1:100) followed by incubation with IgG blocking kit (Vector 
MOM-mouse on mouse- Kit) to avoid unspecific binding. Finally, 
sections were incubated with Fluorescein-Avidin D Cell Sorter 
Grade (Fluorescein-Avidin DCS; Vector Laboratories). Human 
prepuce and mouse skin sections were processed by the same 
method to serve as positive and negative controls respectively. 
For identification of endothelial cells, representative sections of 
each implant were incubated with Anti mouse von Willebrand 
rabbit polyclonal antibody (dilution 1:100, Clotimmun, Boehring 
Institute) that was revealed by a secondary  polyclonal swine 
anti rabbit - FITC conjugated antibody (dilution 1:30, Dako). 
Sections were mounted with 4’, 6-diamidino-2-phenylindole 
(DAPI, Vectashield, Vector) and analyzed through a Zeiss 
Axiophot  confocal microscope equipped  with a LEICA Q55CW 
Cytogenetics Workstation.
DNA extraction and amplification
Four pairs of implants (one of each series) were 
processed for Genomic DNA extraction by TRI-REAGENT kit 
(Euromedex - France), following the protocol recommended 
by the manufacturer. The DNA extracted from each implant 
was separately processed by the polymerase chain reaction 
(PCR), to amplify a fragment of 850-bp of the α-satellite region 
of the human chromosome 17, using the following primers 
(Invitrogen): 5’GGATAATTTCAGCTGACTAAACAG3’ and 
5’TTCCGTTTAGTTAGGTGCAGTTGTTATC3’. Nucleotide 
position corresponds to the sequence HSSATA17 (Gen Bank No. 
M13882). As positive control, human cultured cells were used 
for extraction and amplification of the same DNA fragments 
.Amplified DNA fragments were submitted to electrophoresis in 
2% agarose gels, stained with ethidium bromide and visualized 
through ultra-violet light.
Results
ADSC characterization by FACS
Cells from the second passage from each donor were 
separately analyzed and showed a homogeneous population 
regarding size and morphology. ADSC exhibited markers from 
stromal origin (CD90+, CD13+) and also expressed markers 
of interaction with metalloprotease (CD13+), endothelial cells 
(CD29+), hyaluronic acid (CD44+), molecules of cell-to-cell 
adhesion (CD54+) and fibronectin (CD29+, CD49e+). Expanded 
ADSC did not express markers from hematopoietic lineage 
(CD34/- and CD45/-) and KDR. The mean percentage of positive 
cells for each marker is presented in Table 1, followed by a brief 
markers description. These results are similar to those observed by 
other authors2-5.    
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TABLE 1 - ADSC surface markers profile.
                                                         
CD90-THY-1: cell surface glycoprotein that can be used as a 
marker for a variety of stem cells. CD13-Aminopeptidase N: a zinc 
metalloproteinase, also known as aminopeptidase N, which is found 
naturally on myelomonocytic cells from early differentiation through 
maturity. Integrins (CD29 and CD49e): integrin family members are 
membrane receptors involved in cell adhesion and recognition in a variety 
of processes including embryogenesis, homeostasis, tissue repair, immune 
response and metastatic diffusion of plug cells. CD44-Hyaluronate: a 
family of matrix adhesion molecules that adhere to hyaluronate, collagen, 
laminin, and fibronectin. MHC class 1-HLA class I antigens (A, B & 
C): present peptides from inside the cell. (HLA human leukocyte antigen 
system) is the name of the major histocompatibility complex (MHC) in 
humans. CD54-ICAM 1: intercellular adhesion molecule. CD51/61- 
Integrin alphaV/beta3: vitronectin receptor, high  levels on osteoclasts, 
endothelial cells, and melanoma cells. KDR-VEGFR-2: receptor for 
vascular endothelial growth factor 2.  HDLA-DR-MHC class II: major 
histocompatibility complex,class II cell surface receptor. HLA class II 
antigens (DP, DQ, & DR) present antigens from outside of the cell to 
T-lymphocytes HLA-DR is found in macrophages, B-cells and dendritic 
cells. CD34-PECAM: platelet endothelial cell adhesion molecule. 
CD45/14-PTPRCAP: transmembrane phosphoprotein specifically 
associated with tyrosine phosphatase: markers of hematopoietic lineage. 
Macroscopic analysis
In the dorsum of the animals, at the site of injection 
of ADSC implants, a plug with fibroelastic consistence, could 
be easily identified. At the contra lateral area, where the control 
implant was injected, we observed no plug (Figure 1). After 
harvesting the dorsal flap, the “plug” was identified as a mass of 
white tissue with visible vessels, while the control showed itself 
transparent and avascular (Figures 2a and 2b).
     
FIGURE 1 - ADSC implant in athymic mouse. Two months after the 
injections, arrow shows a plug corresponding to the site of injection of 
ADSC implant. No plug can be seen in the contra-lateral area, where the 
control implant was injected.
FIGURE 2 - Macroscopic observation of implants with two months of 
implantation. a. Arrow indicates the ADSC implant invaded by a rich 
vascular network. b. Arrow points the control implant, showing itself 
transparent and avascular. 
Histological analysis
Hematoxilin-eosin staining: in ADSC implants we 
observed fusiform cells arranged in cord like structures. In control 
implants we observed just an amorphous substance occupying 
the implants. (Results not shown) Immunofluorescence - ADSC 
implants: sections incubated with specific anti-human vimentin 
antibody revealed an uniform distribution of vimentin filaments in 
all over the implants (Figure 3a). Sections incubated with anti von 
Willebrand antibody identified endothelial cells forming vessels 
(Figure 3c), in agreement with the macroscopic observation 
(Figure 2a). Control implants: no vimentin filaments or endothelial 
cells were observed (Figures 3b and 3d).   
Surface Protein Antigen
Mean % Positive Cells
± Standard Error of Mean
Thy-1 CD-90 99.38±0.05
Aminopeptidase N CD-13 98.23±1.44
Integrin 1 CD-29 96.56±0.46
Integrin 5 CD-49e 93.64±2.94
Hyaluronate CD-44 60.18±4.89
MHC- class I HLA-1 46.40±26.7
ICAM-1                                 CD-54 34.78±10.1
alphaVbeta3 complex CD-51/61 4.0±4.2
PECAM CD-34 3.64±3.84
VEGFR-2 KDR 1.66±1.35
MHC- class II HLA/DR 1.54±1.33
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FIGURE 3 - Microscopic analysis of implants sections by 
immunofluorescence. a. Anti-human vimentin-FITC plus DAPI. 400X. 
Note the uniform distribution of human vimentin filaments inside ADSC 
implant. b. Anti-human vimentin-FITC plus DAPI. 400X- Note absence 
of human vimentin filaments in control implant. c. Anti -von Willebrand 
Factor-FITC plus DAPI. 200X. Observe the vessels, indicated by arrows, 
inside ADSC implant. d. Anti -von Willebrand Factor-FITC plus DAPI. 
200X. Note the absence of vessels inside control implant. 
Analysis of PCR product by electrophoresis in agarose 
gels
Analysis of ADSC implants DNA revealed a band 
correspondent to human genomic DNA that could not be identified 
in controls (Figure 4).    
FIGURE 4 - Analysis of PCR product of ADSC implant. Arrow shows 
the band revealed by the electrophoresis in agarose gel of ADSC implant 
PCR product. Hum cell column corresponds to the positive control: 
amplified fragments of 850pb from genomic DNA extracted from cultured 
human cells. Gel only column corresponds to the control implant.
Discussion 
To the present there are no clear evidences that cells used 
in cell therapy are able to engraft by themselves at the injured area 
where they are supposed to exert their therapeutic effect9,10. Suzuki 
et al.17 injected muscular precursors cells in the healthy cardiac 
muscle of immune compatible mice and demonstrated that 55% 
of cells disappeared from muscle, 10 minutes after injection. The 
authors’ findings suggest that the lack of homing of cells in at the 
area of injection may impair their potential therapeutic effect and 
reduce the method efficiency.
Hosting implanted cells in a biodegradable scaffold to 
serve as extra cellular matrix is known to regulate cell adhesion, 
migration and phenotype18-20. Hyaluronan or hyaluronic acid (HA) 
is a glycosaminoglycan that integrates the peri cellular matrix and 
is anchored in cells surface by CD 44, that is expressed by ADSC. 
Furthetmore, cross-linked HA can form cable structures and plays 
a key role in pushing and pulling cells in different physiological 
process, as observed by Evanko et al.14. Still, the biodegraditon 
of HA produces fragments that are angiogenic21-23. Flynn et al.24 
studied implants of ADSC seeded in decellularized placenta 
combined with cross-linked HA, in the subcutaneous of a murine 
model. The authors raised the hypothesis that ADSC promoted 
implant vascularization by secreting chemeotatic cytokines that 
attracted endothelial cells. Further, according to the authors, 
ADSC secreted hyaluroridase that lead to release of HA fragments 
that also contributed to angiogenesis.  
The above mentioned  characteristics and properties, 
added to the fact that HA gel has been routinely used for cosmetic 
treatments25,26 makes it a suitable, readily available scaffold for 
delivering ADSC with therapeutic purposes, as proposed for other 
authors in different experimental models. Ganey et al.27 used 
hyaluronic acid as a carrier for ADSC to treat intervertebral disc 
injury in a canine model and although they have not described 
the physical characteristics of the HA carrier (gel? sponge?), 
they reported disc regeneration. Ito et al.28, studied adipose tissue 
formation in athymic mice, comparing ADSC seeded in HA gel 
or in type I collagen sponge or non-woven polyglycolic acid. 
The authors concluded that although the three scaffolds served 
to support the cells in vivo for eight weeks, type I collagen was 
more efficient to promote adipocyte differentiation. Altman et 
al.29 studied implants of ADSC seeded in nonanimal stabilized 
hyaluronic acid in a photoaged murine model. Although their 
experiment was restrict to three weeks, the authors reported an 
organized fibrovascular network supporting the implants.  
In this model we seeded ADSC in HA gel, 24h prior to the 
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injection, thus providing a scaffold that assured their pervasiveness 
at the site of implantation.  HA may have also contributed to cells 
viability by protecting them from oxidative damage in vitro, as 
demonstrated in other cell types30-32. By adding bFGF to ADSC 
preparations two hour before the injection, we intended to provide 
a signal to boost angiogenesis in the first hours after implantation, 
as other authors have previously suggested33-35. We hypothesize 
that the maintenance of the vascular network for two months in 
ADSC implants was due to the paracrine interaction  between 
engrafted ADSC  and host extra cellular matrix and  endothelial 
cells, added with the pro-angiogenic effect of HA degradation.
Conclusion
In a murine model, human adipose derived stem cells, 
pre-seeded for 24h in HA, engrafted at the site of implantation and 
induced the development of a vascular network that supported the 
implants for two months. 
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